Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.550
-0.290 (-5.99%)
At close: Nov 20, 2024, 4:00 PM
4.560
+0.010 (0.22%)
After-hours: Nov 20, 2024, 4:36 PM EST
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $385.22 million as of November 21, 2024. Its market cap has decreased by -67.69% in one year.
Market Cap
385.22M
Enterprise Value
-83.44M
1-Year Change
-67.69%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $385.22M, a decrease of -55.69%. That is a compound annual growth rate of -21.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 385.22M | -65.64% |
| Dec 29, 2023 | 1.12B | -5.95% |
| Dec 30, 2022 | 1.19B | -32.88% |
| Dec 31, 2021 | 1.78B | 104.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perspective Therapeutics | 412.28M |
| DocGo | 407.18M |
| Canopy Growth | 404.14M |
| Sangamo Therapeutics | 397.47M |
| Akebia Therapeutics | 393.82M |
| enGene Holdings | 392.52M |
| Revance Therapeutics | 392.33M |
| 4D Molecular Therapeutics | 389.70M |